RARRES3 Antikörper (AA 124-136)
RARRES3
Reaktivität: Human
ELISA
Wirt: Ziege
Polyclonal
unconjugated
-
-
Target
Alle RARRES3 Antikörper anzeigen
-
RARRES3
(Retinoic Acid Receptor Responder (Tazarotene Induced) 3 (RARRES3))
-
Bindungsspezifität
-
AA 124-136
-
Reaktivität
-
Human
-
Wirt
-
Ziege
-
Klonalität
-
Polyklonal
-
Konjugat
-
Dieser RARRES3 Antikörper ist unkonjugiert
-
Applikation
-
ELISA
-
Verwendungszweck
-
Goat polyclonal antibody raised against synthetic peptide of RARRES3.
-
Sequenz
-
KSRCKQVEKA KVE
-
Kreuzreaktivität
-
Human
-
Produktmerkmale
-
Antibody Reactive Against Synthetic Peptide.
-
Immunogen
-
A synthetic peptide corresponding to amino acids 124-136 of human RARRES3.
-
Top Product
-
Discover our top product RARRES3 Primärantikörper
-
-
-
Applikationshinweise
-
ELISA (1:128000)
The optimal working dilution should be determined by the end user.
-
Beschränkungen
-
Nur für Forschungszwecke einsetzbar
-
-
Format
-
Liquid
-
Konzentration
-
0.5 mg/mL
-
Buffer
-
In Tris saline, pH 7.3 (0.5 % BSA, 0.02 % sodium azide)
-
Konservierungsmittel
-
Sodium azide
-
Vorsichtsmaßnahmen
-
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
-
-20 °C
-
Informationen zur Lagerung
-
Store at -20°C.
Aliquot to avoid repeated freezing and thawing.
-
-
Tsai, Shyu, Jiang: "RIG1 suppresses Ras activation and induces cellular apoptosis at the Golgi apparatus." in: Cellular signalling, Vol. 19, Issue 5, pp. 989-99, (2007) (PubMed).
-
-
Target
-
RARRES3
(Retinoic Acid Receptor Responder (Tazarotene Induced) 3 (RARRES3))
-
Andere Bezeichnung
-
RARRES3 (RARRES3 Produkte)
-
Synonyme
-
HRASLS4 antikoerper, HRSL4 antikoerper, PLA1/2-3 antikoerper, RIG1 antikoerper, TIG3 antikoerper, MGC68773 antikoerper, RARRES3 antikoerper, retinoic acid receptor responder 3 antikoerper, retinoic acid receptor responder (tazarotene induced) 3 L homeolog antikoerper, zgc:92249 antikoerper, RARRES3 antikoerper, rarres3.L antikoerper, zgc:92249 antikoerper
-
Gen-ID
-
5920
-